Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI dynamic registry)

American Journal of Cardiology

Volumn 108, Issue 11, 2011, Pages 1658-1664

  Green, Sandy M ^a   Selzer, Faith ⁱ   Mulukutla, Suresh R ^a,i   Tadajweski, Edward J ^a   Green, Jamie A ^a   Wilensky, Robert L ^b   Laskey, Warren K ^c   Cohen, Howard A ^d   Rao, Sunil V ^e   Weisbord, Steven D ^a,f   Lee, Joon S ^a   Reis, Steven E ^a   Kip, Kevin E ^g   Kelsey, Sheryl F ⁱ   Williams, David O ^h   Marroquin, Oscar C ^a,i  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARE METAL STENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG ELUTING STENT; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVASCULARIZATION; RISK ASSESSMENT; TREATMENT OUTCOME;

AGED; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 80955158525     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.07.029     Document Type: Article

References (30)

1. J. Coresh, E. Selvin, L.A. Stevens, J. Manzi, J.W. Kusek, P. Eggers, F. Van Lente, and A.S. Levey Prevalence of chronic kidney disease in the United States JAMA 298 2007 2038 2047
2. F.E. Yeo, T.C. Villines, J.R. Bucci, A.J. Taylor, and K.C. Abbott Cardiovascular risk in stage 4 and 5 nephropathy Adv Chronic Kidney Dis 11 2004 116 133
3. J. Al Suwaidi, D.N. Reddan, K. Williams, K.S. Pieper, R.A. Harrington, R.M. Califf, C.B. Granger, E.M. Ohman, D.R. Holmes Jr GUSTO-IIb, GUSTO-III, PURSUIT Global Use of Strategies to Open Occluded Coronary Arteries; Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy; PARAGON-A Investigators: Platelet IIb/IIIa Antagonism for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes Circulation 106 2002 974 980
4. J.F. Mann, H.C. Gerstein, J. Pogue, J. Bosch, and S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
5. D.L. Fischman, M.B. Leon, D.S. Baim, R.A. Schatz, M.P. Savage, I. Penn, K. Detre, L. Veltri, D. Ricci, M. Nobuyoshi, M. Cleman, R. Heuser, D. Almond, P. Terirstein, D. Fish, A. Colombo, J. Brinker, J. Moses, A. Shanknovich, J. Hirshfeld, S. Bailiey, S. Elis, R. Rake, and S. Goldberg A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease Stent Restenosis Study Investigators N Engl J Med 331 1994 496 501
6. N. Attallah, L. Yassine, K. Fisher, and J. Yee Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention Clin Nephrol 64 2005 412 418
7. M.C. Morice, P.W. Serruys, J.E. Sousa, J. Fajadet, E. Ban Hayashi, M. Perin, A. Colombo, G. Schuler, P. Barragan, G. Guagliumi, F. Molnr, R. Falotico RAVEL Study Group Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
8. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, C. O'Shaughnessy, R.P. Caputo, D.J. Kereiakes, D.O. Williams, P.S. Teirstein, J.L. Jaeger, R.E. Kuntz SIRIUS Investigators Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
9. A. Farb, and A.B. Boam Stent thrombosis reduxthe FDA perspective N Engl J Med 356 2007 984 987
10. E. Schampaert, E.A. Cohen, M. Schlter, F. Reeves, M. Traboulsi, L.M. Title, R.E. Kuntz, J.J. Popma C-SIRIUS Investigators The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115
11. A.T. Ong, E.P. McFadden, E. Regar, P.P. de Jaegere, R.T. van Domburg, and P.W. Serruys Late angiographic stent thrombosis (LAST) events with drug-eluting stents J Am Coll Cardiol 45 2005 2088 2092
12. M. Pfisterer, H.P. Brunner-La Rocca, P.T. Buser, P. Rickenbacher, P. Hunziker, C. Mueller, R. Jeger, F. Bader, S. Osswald, C. Kaiser BASKET-LATE Investigators Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
13. A.J. Nordmann, M. Briel, and H.C. Bucher Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis Eur Heart J 27 2006 2784 2814
14. E. Camenzind, P.G. Steg, and W. Wijns Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 2007 1440 1455
15. I. Moussa, C. Di Mario, B. Reimers, T. Akiyama, J. Tobis, and A. Colombo Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome J Am Coll Cardiol 29 1997 6 12
16. D.O. Williams, R. Holubkov, W. Yeh, M.G. Bourassa, M. Al-Bassam, P.C. Block, P. Coady, H. Cohen, M. Cowley, G. Dorros, D. Faxon, D.R. Holmes, A. Jacobs, S.F. Kelsey, S.B. King III, R. Myler, J. Slater, V. Stanek, H.A. Vlachos, and K.M. Detre Percutaneous coronary intervention in the current era compared with 19851986: the National Heart, Lung, and Blood Institute Registries Circulation 102 2000 2945 2951
17. N.S. Anavekar, J.J. McMurray, E.J. Velazquez, S.D. Solomon, L. Kober, J.L. Rouleau, H.D. White, R. Nordlander, A. Maggioni, K. Dickstein, S. Zelenkofske, J.D. Leimberger, R.M. Califf, and M.A. Pfeffer Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction N Engl J Med 351 2004 1285 1295
18. L. Gruberg, G. Dangas, R. Mehran, G.S. Mintz, K.M. Kent, A.D. Pichard, L.F. Satler, A.J. Lansky, G.W. Stone, and M.B. Leon Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure Catheter Cardiovasc Interv 55 2002 66 72
19. L.A. Szczech, P.J. Best, E. Crowley, M.M. Brooks, P.B. Berger, V. Bittner, B.J. Gersh, R. Jones, R.M. Califf, H.H. Ting, P.J. Whitlow, K.M. Detre, D. Holmes Bypass Angioplasty Revascularization Investigation (BARI) Investigators Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation Circulation 105 2002 2253 2258
20. S.R. Dixon, W.W. O'Neill, H.M. Sadeghi, G.W. Stone, B. Brodie, D.A. Cox, E. Garcia, L. Mattos, L.L. Grines, J.A. Boura, M.C. Morice, and C.L. Grines Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction Am J Cardiol 91 2003 1454 1457
21. D.W. Schwertz, and P. Vaitkus Drug-eluting stents to prevent reblockage of coronary arteries J Cardiovasc Nurs 18 2003 11 16
22. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
23. S.E. Reis, M.B. Olson, L. Fried, V. Reeser, S. Mankad, C.J. Pepine, R. Kerensky, C.N. Merz, B.L. Sharaf, G. Sopko, W.J. Rogers, and R. Holubkov Mild renal insufficiency is associated with angiographic coronary artery disease in women Circulation 105 2002 2826 2829
24. P. Garg, D.M. Charytan, L. Novack, D.E. Cutlip, J.J. Popma, J. Moses, M.B. Leon, J. Schofer, G. Breithardt, E. Schampaert, and L. Mauri Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials) Am J Cardiol 106 2010 1436 1442
25. F. Latif, N.S. Kleiman, D.J. Cohen, M.J. Pencina, C.H. Yen, D.E. Cutlip, D.J. Moliterno, D. Nassif, J.J. Lopez, J.F. Saucedo EVENT Investigators In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry JACC Cardiovasc Interv 2 2009 37 45
26. D.M. Charytan, M.R. Varma, T.S. Silbaugh, A.F. Lovett, S.L. Normand, and L. Mauri Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry Am J Kidney Dis 57 2011 202 211
27. P. Alexander, S. David, and P.A. McCullough Drug-eluting coronary stents in patients with kidney disease Am J Kidney Dis 57 2011 188 189
28. V. Rigalleau, C. Lasseur, C. Perlemoine, N. Barthe, C. Raffaitin, C. Liu, P. Chauveau, L. Baillet-Blanco, M.C. Beauvieux, C. Combe, and H. Gin Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or Modification of Diet in Renal Disease study equation? Diabetes Care 28 2005 838 843
29. N. Berman, and T.H. Hostetter Comparing the Cockcroft-Gault and MDRD equations for calculation of GFR and drug doses in the elderly Nat Clin Pract Nephrol 3 2007 644 645
30. A.S. Levey, P.E. de Jong, J. Coresh, M.E. Nahas, B.C. Astor, K. Matsushita, R.T. Gansevoort, B.L. Kasiske, and K.U. Eckardt The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report Kidney Int 80 2011 17 28